BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 25934483)

  • 21. Elevated homocysteine and asymmetric dimethyl arginine levels in pulmonary hypertension associated with congenital heart disease.
    Sanli C; Oguz D; Olgunturk R; Tunaoglu FS; Kula S; Pasaoglu H; Gulbahar O; Cevik A
    Pediatr Cardiol; 2012 Dec; 33(8):1323-31. PubMed ID: 22526220
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Circulating NEDD9 is increased in pulmonary arterial hypertension: A multicenter, retrospective analysis.
    Samokhin AO; Hsu S; Yu PB; Waxman AB; Alba GA; Wertheim BM; Hopkins CD; Bowman F; Channick RN; Nikolic I; Faria-Urbina M; Hassoun PM; Leopold JA; Tedford RJ; Ventetuolo CE; Leary PJ; Maron BA
    J Heart Lung Transplant; 2020 Apr; 39(4):289-299. PubMed ID: 31952977
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correlation between congenital heart disease complicated with pulmonary artery hypertension and circulating endothelial cells as well as endothelin-1.
    Li X; Qiu J; Pan M; Zheng D; Su Y; Wei M; Kong X; Sun W; Zhu J
    Int J Clin Exp Pathol; 2015; 8(9):10743-51. PubMed ID: 26617785
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Angiogenic and inflammatory biomarkers in the differentiation of pulmonary hypertension.
    Säleby J; Bouzina H; Lundgren J; Rådegran G
    Scand Cardiovasc J; 2017 Oct; 51(5):261-270. PubMed ID: 28776404
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pulmonary arterial capacitance in children with idiopathic pulmonary arterial hypertension and pulmonary arterial hypertension associated with congenital heart disease: relation to pulmonary vascular resistance, exercise capacity, and survival.
    Sajan I; Manlhiot C; Reyes J; McCrindle BW; Humpl T; Friedberg MK
    Am Heart J; 2011 Sep; 162(3):562-8. PubMed ID: 21884877
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Utility of right ventricular Tei index in the noninvasive evaluation of chronic thromboembolic pulmonary hypertension before and after pulmonary thromboendarterectomy.
    Blanchard DG; Malouf PJ; Gurudevan SV; Auger WR; Madani MM; Thistlethwaite P; Waltman TJ; Daniels LB; Raisinghani AB; DeMaria AN
    JACC Cardiovasc Imaging; 2009 Feb; 2(2):143-9. PubMed ID: 19356547
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma L-arginine levels distinguish pulmonary arterial hypertension from left ventricular systolic dysfunction.
    Sandqvist A; Schneede J; Kylhammar D; Henrohn D; Lundgren J; Hedeland M; Bondesson U; Rådegran G; Wikström G
    Heart Vessels; 2018 Mar; 33(3):255-263. PubMed ID: 28975394
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic value of acute vasodilator response in pulmonary arterial hypertension: beyond the "classic" responders.
    Halliday SJ; Hemnes AR; Robbins IM; Pugh ME; Zhao DX; Piana RN; Fong PP; Brittain EL
    J Heart Lung Transplant; 2015 Mar; 34(3):312-8. PubMed ID: 25577565
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pentraxin3 in chronic thromboembolic pulmonary hypertension: a new biomarker for screening from remitted pulmonary thromboembolism.
    Naito A; Tanabe N; Jujo T; Shigeta A; Sugiura T; Sakao S; Ishida K; Tatsumi K
    PLoS One; 2014; 9(11):e113086. PubMed ID: 25412085
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic Value of Oxidative Stress Markers in Patients with Pulmonary Arterial or Chronic Thromboembolic Pulmonary Hypertension.
    Smukowska-Gorynia A; Rzymski P; Marcinkowska J; Poniedziałek B; Komosa A; Cieslewicz A; Slawek-Szmyt S; Janus M; Araszkiewicz A; Jankiewicz S; Tomaszewska-Krajniak I; Mularek-Kubzdela T
    Oxid Med Cell Longev; 2019; 2019():3795320. PubMed ID: 31929853
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma Levels of Receptor for Advanced Glycation End-Products and High-Mobility Group Box 1 in Patients With Pulmonary Hypertension.
    Suzuki S; Nakazato K; Sugimoto K; Yoshihisa A; Yamaki T; Kunii H; Suzuki H; Saitoh S; Takeishi Y
    Int Heart J; 2016; 57(2):234-40. PubMed ID: 26973260
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Asymmetrical dimethylarginine in systemic sclerosis-related pulmonary arterial hypertension.
    Dimitroulas T; Giannakoulas G; Sfetsios T; Karvounis H; Dimitroula H; Koliakos G; Settas L
    Rheumatology (Oxford); 2008 Nov; 47(11):1682-5. PubMed ID: 18753191
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Asymmetric dimethylarginine (ADMA) and soluble vascular cell adhesion molecule 1(sVCAM-1) as circulating markers for endothelial dysfunction in patients with pheochromocytoma.
    Vasilev V; Matrozova J; Elenkova A; Vandeva S; Kirilov G; Zacharieva S
    Exp Clin Endocrinol Diabetes; 2013 Oct; 121(9):551-5. PubMed ID: 24002898
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oxidative stress markers and C-reactive protein are related to severity of heart failure in patients with dilated cardiomyopathy.
    Wojciechowska C; Romuk E; Tomasik A; Skrzep-Poloczek B; Nowalany-Kozielska E; Birkner E; Jacheć W
    Mediators Inflamm; 2014; 2014():147040. PubMed ID: 25400332
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acute effects of the combination of sildenafil and inhaled treprostinil on haemodynamics and gas exchange in pulmonary hypertension.
    Voswinckel R; Reichenberger F; Enke B; Kreckel A; Krick S; Gall H; Schermuly RT; Grimminger F; Rubin LJ; Olschewski H; Seeger W; Ghofrani HA
    Pulm Pharmacol Ther; 2008 Oct; 21(5):824-32. PubMed ID: 18657627
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Utility of right ventricular Tei-index for assessing disease severity and determining response to treatment in patients with pulmonary arterial hypertension.
    Ogihara Y; Yamada N; Dohi K; Matsuda A; Tsuji A; Ota S; Ishikura K; Nakamura M; Ito M
    J Cardiol; 2014 Feb; 63(2):149-53. PubMed ID: 24012334
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Pre- and postoperative assessment of hemodynamics in patients with chronic thromboembolic pulmonary hypertension by MR techniques].
    Ley S; Kramm T; Kauczor HU; Mayer E; Heussel CP; Thelen M; Kreitner KF
    Rofo; 2003 Dec; 175(12):1647-54. PubMed ID: 14661135
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Involvement of asymmetric dimethylarginine and Rho kinase in the vascular remodeling in monocrotaline-induced pulmonary hypertension.
    Li XH; Peng J; Tan N; Wu WH; Li TT; Shi RZ; Li YJ
    Vascul Pharmacol; 2010; 53(5-6):223-9. PubMed ID: 20840872
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Changes in plasma levels of asymmetric dimethylarginine, symmetric dimethylarginine, and arginine after a single dose of vardenafil in patients with pulmonary hypertension.
    Henrohn D; Sandqvist A; Egeröd H; Hedeland M; Wernroth L; Bondesson U; Wikström G
    Vascul Pharmacol; 2015 Oct; 73():71-7. PubMed ID: 25934511
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of prolonged submaximal exercise on serum oxidative stress biomarkers (d-ROMs, MDA, BAP) and oxidative stress index in endurance horses.
    Brkljača Bottegaro N; Gotić J; Šuran J; Brozić D; Klobučar K; Bojanić K; Vrbanac Z
    BMC Vet Res; 2018 Jul; 14(1):216. PubMed ID: 29980209
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.